Cancer-Killing Viruses Enter in Stealth Mode, Penetrate Immune Barrier

Viruses that, when administered to patients, preferentially attack and kill cancer cells, leaving normal tissues unscathed. It might sound like science fiction, but oncolytic viruses are, in fact, already a (small) part of oncologists’ toolkit. Five years ago, the U.S. FDA approved the first and only oncolytic virus therapy called talimogene laherparepvec (T-VEC, or…

--

--

--

Follow me for bite-sized stories on the latest discoveries and innovations in biomedical research.

Love podcasts or audiobooks? Learn on the go with our new app.

Recommended from Medium

Statistically Significant Haikus

The Viral Origins of Our Intelligence

Down the drain? Not waste after all!

The Adaptive Immune System

JSPS RONPAKU (Dissertation PhD) Program

How CRISPR/Cas works inside bacteria

Louis Pasteur: More than Just Milk

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
River D'Almeida, Ph.D

River D'Almeida, Ph.D

Follow me for bite-sized stories on the latest discoveries and innovations in biomedical research.

More from Medium

At Genetic Risk for Alzheimer's? Eat Your Fruits and Veggies

Violet Extract Boosts Brain Cancer Drug’s Performance

The Implications Of Clotting In A Heart Attack

Researchers Stumble Upon Cancer Drug While Studying Flesh-Eating Bacteria